Flightpath Biosciences operates an Australian subsidiary to conduct critical phase I human clinical studies in an efficient, high quality clinical environment.

MATT TINDALL, MBA

Mr. Tindall has extensive leadership experience as a Board Chairman, CEO, Executive and Founder of life sciences companies across multiple therapeutic modalities and domains including, rare disease, cardiovascular disease, neurology, oncology, infectious disease and bioinformatics. Over the past two decades, Mr Tindall led teams at Fabric Genomics (acquired by GeneDx), IMS Health (now IQVIA), Digitas […]

Adele Hosseini, PhD

Adele Hosseini, PhD is a pharmacist with more than 30 years of experience in leadership, global clinical research, regulatory affairs, and academia. Her career spans pharmaceuticals, clinical research organizations, medical devices, and university lecturing.